In models of asthma and parasitic infections, blocking any of IL-25, IL-33, or TSLP alone showed only modest results, while combinatorial targeting of IL-33, IL-25 and TSLP significantly reduced collagen expression and fibrosis [123]. The gene discussed is IL33; the disease is asthma.